Arrowhead Pharmaceuticals, Inc. Common Stock logo

Arrowhead Pharmaceuticals, Inc. Common Stock (ARWR) Technical Analysis

$65.45▲-0.71%

Market is closed - opens 7 PM, 29 Sep 2026

Insights

  • Arrowhead Pharmaceuticals Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Arrowhead Pharmaceuticals Inc. stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Arrowhead Pharmaceuticals Inc. stock is in a downtrend↘️
  • Based on analysis of the Pivot Points, the current market trend for Arrowhead Pharmaceuticals Inc. stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
31.19
Neutral
Stochastic
6.26, 8.0
Neutral
Ultimate Oscillator
34.82
Neutral
Stochastic Relative Strength Index
35.0, 38.62
Neutral
Moving Average Convergence Divergence
-5.05, -3.87
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
69.1
Sell
20
76.63
Sell
50
82.21
Buy

Exponential Moving Average

Period (Days)

Value

Action

10
70.13
Sell
20
74.58
Sell
50
78.93
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
69.54
Sell
20
74.55
Sell
50
80.12
Sell

Double Exponential Moving Average

Period (Days)

Value

Action

10
65.2
Sell
20
68.25
Sell
50
77.01
Sell

Triple Exponential Moving Average

Period (Days)

Value

Action

10
64.72
Buy
20
64.53
Sell
50
72.66
Sell

Pivot

Pivot

Value

Resistance L3
69.18
Resistance L2
68.32
Resistance L1
67.19
Pivot Point
66.33
Support L1
65.2
Support L2
64.34
Support L3
63.21

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.